Camlin Fine Sciences Complete Financial Statements
12 Years of Data
2026 - 2015
In FY2026, Camlin Fine Sciences (CAMLINFINE) reported revenue ₹535 Cr, net profit ₹86 Cr and EPS ₹4.59, with a net profit margin of 16.1% and ROE of 8.3%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Examine CAMLINFINE quarterly performance for recent quarterly revenue, profit and EPS trends.
Complete Financial Data Export
Profitability Ratios
Net Profit Margin
16.07%
2026 data
EBITDA Margin
23.18%
2026 data
Operating Margin
3.00%
2026 data
Return on Assets
3.70%
2026 data
Return on Equity
8.26%
2026 data
Balance Sheet Ratios
Current Ratio
3.54
2026 data
Equity Ratio
44.79%
2026 data
Asset Turnover
0.23
2026 data
CAMLINFINE Revenue, Net Profit & EBITDA — Year-on-Year Growth
CAMLINFINE YoY (Mar 2025 vs Mar 2026) — revenue +20.2%, EBITDA +210.0%, expenses +1.7%. Analyse CAMLINFINE FII DII holdings to track promoter, FII and institutional holdings.
Revenue Growth
+20.2%
Year-over-Year
EBITDA Growth
+210.0%
Year-over-Year
Expense Growth
+1.7%
Year-over-Year
Assets Growth
+14.8%
Year-over-Year
Equity Growth
+19.0%
Year-over-Year
Operating Cash Flow Growth
-80.6%
Year-over-Year
Investing Cash Flow Growth
-11.9%
Year-over-Year
Financing Cash Flow Growth
+183.7%
Year-over-Year
CAMLINFINE Income Statement — Revenue, EBITDA & Net Profit
Camlin Fine Sciences revenue ₹535 Cr, EBITDA ₹124 Cr, net profit ₹86 Cr, EPS ₹4.59 (2026) — net profit margin 16.1%. For live price, earnings ratios and company overview, see Camlin Fine Sciences stock price NSE.
Periods
₹ Crores
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Mar 2018 | Jun 2018 | Dec 2018 | Sept 2017 | Mar 2017 | Jun 2017 | Dec 2017 | Sept 2016 | Mar 2016 | Jun 2016 | Dec 2016 | Sept 2015 | Mar 2015 | Jun 2015 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 535 | 464 | 445 | 433 | 443 | 429 | 382 | 383 | 432 | 408 | 429 | 426 | 388 | 486 | 411 | 385 | 398 | 312 | 329 | 341 | 386 | 258 | 296 | 306 | 299 | 223 | 273 | 261 | 275 | 211 | 241 | 185 | 242 | 150 | 153 | 139 | 210 | 111 | 132 | 142 | 143 | 115 | 152 | 123 | 119 |
| Expenses | 412 | 436 | 405 | 411 | 447 | 529 | 446 | 368 | 384 | 381 | 393 | 381 | 363 | 428 | 365 | 337 | 338 | 289 | 276 | 285 | 326 | 223 | 259 | 255 | 251 | 192 | 251 | 225 | 244 | 184 | 221 | 168 | 226 | 142 | 158 | 150 | 202 | 94 | 104 | 122 | 132 | 99 | 120 | 94 | 106 |
| EBITDA | 124 | 29 | 40 | 22 | -4 | -100 | -64 | 14 | 48 | 27 | 36 | 45 | 25 | 58 | 46 | 48 | 60 | 23 | 53 | 56 | 61 | 35 | 37 | 52 | 48 | 31 | 21 | 36 | 30 | 27 | 19 | 18 | 16 | 8 | -6 | -11 | 8 | 17 | 28 | 21 | 11 | 16 | 32 | 29 | 14 |
| Operating Profit Margin % | 3.00% | 5.00% | 6.00% | 3.00% | -1.00% | -27.00% | -19.00% | 3.00% | 11.00% | 6.00% | 8.00% | 9.00% | 6.00% | 11.00% | 6.00% | 12.00% | 13.00% | 7.00% | 15.00% | 14.00% | 14.00% | 13.00% | 12.00% | 17.00% | 16.00% | 14.00% | 6.00% | 14.00% | 11.00% | 9.00% | 5.00% | 8.00% | 6.00% | 3.00% | -5.00% | -8.00% | 3.00% | 16.00% | 21.00% | 11.00% | 1.00% | 13.00% | 17.00% | 23.00% | 11.00% |
| Depreciation | 21 | 19 | 17 | 17 | 16 | 17 | 13 | 15 | 15 | 19 | 18 | 19 | 21 | 14 | 16 | 14 | 16 | 13 | 12 | 13 | 13 | 10 | 9 | 10 | 13 | 8 | 7 | 8 | 8 | 8 | 10 | 7 | 7 | 6 | 6 | 5 | 6 | 6 | 5 | 5 | 6 | 4 | 5 | 4 | 4 |
| Interest | 23 | 19 | 15 | 16 | 17 | 26 | 16 | 23 | 34 | 20 | 10 | 10 | 14 | 19 | 10 | 19 | 12 | 9 | 12 | 10 | 7 | 8 | 15 | 11 | 7 | 14 | 7 | 6 | 8 | 10 | 4 | 9 | 11 | 8 | 5 | 6 | 10 | 6 | 7 | 7 | 9 | 6 | 7 | 6 | 6 |
| Profit Before Tax | 80 | -9 | 8 | -11 | -37 | -142 | -94 | -24 | 0 | -12 | 8 | 16 | -10 | 26 | 20 | 15 | 32 | 1 | 29 | 33 | 41 | 17 | 13 | 32 | 28 | 9 | 7 | 23 | 14 | 10 | 5 | 2 | -2 | -6 | -17 | -22 | -8 | 6 | 17 | 9 | -3 | 8 | 20 | 20 | 5 |
| Tax | -6 | 6 | 8 | 0 | 0 | -26 | -12 | 11 | 7 | 9 | 5 | 4 | 5 | 16 | 7 | 11 | 9 | 5 | 13 | 9 | 14 | 8 | 11 | 11 | 8 | 1 | 0 | 6 | 10 | 8 | 10 | 6 | -1 | -3 | -12 | -10 | -3 | 5 | 3 | 6 | 0 | 3 | -3 | 6 | 2 |
| Net Profit | 86 | -15 | 0 | -11 | -37 | -116 | -82 | -35 | -8 | -21 | 4 | 12 | -14 | 10 | 13 | 4 | 23 | -4 | 16 | 24 | 27 | 10 | 2 | 21 | 19 | 8 | 6 | 16 | 4 | 2 | -4 | -4 | -1 | -3 | -5 | -11 | -5 | 1 | 14 | 3 | -4 | 5 | 23 | 14 | 3 |
| Earnings Per Share (₹) | 4.59 | -0.76 | -1.25 | -0.53 | -2.38 | -5.88 | -4.64 | -2.00 | -0.71 | -1.17 | 0.59 | 0.96 | -0.71 | 0.83 | 1.16 | 0.37 | 1.53 | -0.43 | 1.16 | 1.75 | 2.25 | 0.49 | 0.22 | 1.27 | 1.26 | 0.57 | 0.60 | 1.28 | 0.43 | 0.11 | -0.66 | -0.49 | -0.17 | -0.40 | -0.85 | -1.16 | -1.36 | 0.07 | 1.48 | 0.12 | -0.33 | 0.53 | 0.47 | 1.45 | 0.27 |
CAMLINFINE Balance Sheet — Assets, Liabilities & Shareholders' Equity
CAMLINFINE total assets ₹2,324 Cr, total equity ₹1,041 Cr, total liabilities ₹ Cr (2026) — ROE 8.3%.
Years
Annual Data
₹ Crores
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 2,324 | 2,024 | 1,952 | 2,060 | 1,800 | 1,482 | 1,234 | 1,087 | 1,017 | 673 | 483 | 430 |
| Current Assets | 1,237 | 1,183 | 1,001 | 1,088 | 894 | 795 | 675 | 673 | 666 | 419 | 300 | 299 |
| Fixed Assets | 687 | 704 | 816 | 858 | 601 | 584 | 306 | 272 | 278 | 201 | 140 | 106 |
| Capital Work in Progress | 33 | 10 | 46 | 43 | 215 | 24 | 179 | 59 | 14 | 8 | 25 | 3 |
| Investments | 504 | 61 | 8 | 8 | 7 | 7 | 7 | 11 | 115 | 19 | 0 | 0 |
| Other Assets | 0 | 1,249 | 1,082 | 1,152 | 977 | 867 | 742 | 745 | 609 | 445 | 317 | 320 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 349 | 303 | 363 | 443 | 440 | 291 | 226 | 196 | 112 | 57 | 27 | 33 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 1,041 | 875 | 857 | 824 | 765 | 713 | 460 | 430 | 433 | 230 | 176 | 135 |
| Share Capital | 19 | 19 | 17 | 16 | 16 | 13 | 12 | 12 | 12 | 10 | 10 | 10 |
| Reserves & Surplus | 1,022 | 880 | 845 | 800 | 729 | 582 | 388 | 335 | 359 | 202 | 167 | 125 |
CAMLINFINE Cash Flow Statement — Operating, Investing & Financing
Camlin Fine Sciences operating cash flow ₹27 Cr, investing ₹-75 Cr, financing ₹72 Cr, net cash flow ₹24 Cr (2025).
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 27 | 139 | 51 | 145 | 117 | 86 | -9 | -15 | -9 | 72 | 46 |
| Investing Activities | -75 | -67 | -125 | -249 | -133 | -90 | -2 | -149 | -70 | -66 | -26 |
| Financing Activities | 72 | -86 | 60 | 136 | 39 | 3 | 26 | 182 | 91 | -7 | -16 |
| Net Cash Flow | 24 | -14 | -14 | 32 | 23 | -1 | 15 | 18 | 13 | -1 | 5 |